Involvement of dopamine D3 receptors in the area postrema in R( +)-7-OH-DPAT-induced emesis in the ferret

European Journal of Pharmacology

Volumn 301, Issue 1-3, 1996, Pages 143-149

  Yoshikawa, Takashi ^a   Yoshida, Naoyuki ^a   Hosoki, Kanoo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

(Ferret); Area postrema; Dopamine D3 receptor; Emesis; R (+) 7 OH DPAT (R (+) 7 hydroxy 2 (N,N di n propylamino)tetralin)

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; CISPLATIN; DOMPERIDONE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; ETICLOPRIDE; QUINPIROLE; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; ANTIEMETIC AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; EMETIC AGENT; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA POSTREMA; ARTICLE; BRAIN FOURTH VENTRICLE; BRAIN INJURY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; ENANTIOMER; FERRET; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION; VAGOTOMY; VOMITING; ANIMAL; BRAIN VENTRICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG POTENTIATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIEMETICS; CEREBRAL VENTRICLES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMETICS; FERRETS; INJECTIONS, INTRAVENTRICULAR; MALE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TETRAHYDRONAPHTHALENES; VAGOTOMY; VOMITING;

EID: 0029658991     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00061-1     Document Type: Article

References (34)

1. Ahlenius, S. and P. Salmi, 1994, Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat, Eur. J. Pharmacol. 260, 177.
2. Andrews, P.L.R., 1990, The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity, Can. J. Physiol. Pharmacol. 68, 325.
3. 3 receptors, Eur. J. Pharmacol. 239, 269.
4. Beleslin, D.B. and K.R. Krstic, 1986, Dimethylphenylpiperazinium-induced vomiting: nicotinic mediation in area postrema, Brain Res. Bull. 16, 5.
5. 3 receptors. Neuropharmacology 31, 735.
6. 2 receptor mRNA, Brain Res. 564, 203.
7. Caine, S.B. and G.F. Koob, 1993, Modulation of cocaine self-administration in the rat through dopamine D-3 receptors, Science 260, 1814.
8. Carpenter, D.O., 1989, Central nervous system mechanisms in deglutition and emesis, in: Handbook of Physiology, Sect. 6: The Gastrointestinal System, Vol. I, Chapt. 18 (Am. Physiol. Soc., Bethesda, MD) p. 685.
9. Carpenter, D.O., 1990, Neural mechanisms of emesis, Can. J. Physiol. Pharmacol. 68, 230.
10. Daly, S.A. and J.L. Waddington, 1993, Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other 'D2-like' agonists, Neuropharmacology 32, 509.
11. 3 receptor ligand, Eur. J. Pharmacol. 249, R9.
12. 2 dopamine receptor isoforms, Nature 342, 923.
13. 3 receptor agonist, 7-hydroxy-N, N-di-n-propyl-2-aminotetralin, reduces gastric acid and pepsin secretion and experimental gastric mucosal injury in rats. Life Sci. 56, 287.
14. Harding, R.K., H. Hugenholtz, J. Kucharczyk and J. Lemoine, 1987, Central mechanisms for apomorphine-induced emesis in the dog, Eur. J. Pharmacol. 144, 61.
15. Hawthorn, J., K.J. Ostler and P.L.R. Andrews, 1988, The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by cytotoxic drugs cyclophosphamide and cisplatin in the ferret, Quart. J. Exp. Physiol. 73, 7.
16. 3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret, Br. J. Pharmacol. 97, 247.
17. Jovanovic-Micic, D., R. Samardzic and D.B. Beleslin, 1995, The role of α-adrenergic mechanisms within the area postrema in dopamine-induced emesis, Eur. J. Pharmacol. 272, 21.
18. King, G.L., 1990, Animal models in the study of vomiting, Can. J. Physiol. Pharmacol. 68, 260.
19. Klein, R.L., C.L. Graves, Y.I. Kim and R. Blatnick, 1970, Inhibition of apomorphine-induced vomiting by benzquinamide, Clin. Pharmacol. Ther. 11, 530.
20. 3H]hydroxy-N, N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. USA 89, 8155.
21. Lucot, J.B. and G.H. Crampton, 1989, 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine, Pharmacol. Biochem. Behav. 33, 627.
22. 3-selective receptor agonist, produces contralateral rotation in 6-hydroxy-dopamine-lesioned rats, Drug Dev. Res. 34, 329.
23. Millan, M.J., V. Audinot, J.-M. Rivet, A. Gobert, J. Vian, J.-F. Prost, M. Spedding and J.-L. Peglion, 1994, S14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats, Eur. J. Pharmacol. 260, R3.
24. 2 receptors produced by alternative RNA splicing, Nature 342, 926.
25. 1A receptor agonists in Suncus murinus, Jpn. J. Pharmacol. 64, 109.
26. Procter, J.D., A.N. Chremos, E.F. Evans and A.J. Wasserman, 1978, An apomorphine-induced vomiting model for antiemetic studies in man, J. Clin. Pharmacol. 18, 95.
27. 3 receptor antagonist, (+)-S 14297, Eur. J. Pharmacol. 265, 175.
28. Seeman, P. and H.H.M. Van Tol, 1994, Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15, 264.
29. 3) as a target for neuroleptics, Nature 347, 146.
30. Van den Buuse, M., 1993, Effects of 7-hydroxy-N, N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats, Eur. J. Pharmacol. 243, 169.
31. 4 receptor with high affinity for the antipsychotic clozapine, Nature 351, 610.
32. Yoshida, N., H. Omoya and T. Ito, 1992, DAT-582, a novel serotonin 3 receptor antagonist is a potent and long lasting anti-emetic agent in the ferret and dog, J. Parmacol. Exp. Ther. 260, 1151.
33. 3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog, Life Sci. 57, PL347.
34. 1A receptor ligand, J. Med. Cem. 36, 3161.